Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina Kakalacheva

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Future Microbiology|December 8, 2010
Epstein-Barr virus and multiple sclerosis: causation or association?Kristina Kakalacheva, Manuel Comabella
FEBS Letters|April 14, 2011
Environmental triggers of multiple sclerosisKristina Kakalacheva, Jan D Lünemann
Biochimica Et Biophysica Acta|July 6, 2010
Viral triggers of multiple sclerosisKristina Kakalacheva, Christian Münz, Jan D Lünemann
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2011
EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapyManuel Comabella, Kristina Kakalacheva, Jordi Río, et al.
Annals of Neurology|September 10, 2011
Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravisKristina Kakalacheva, Michael A Maurer, Björn Tackenberg, et al.
Journal of Neuroimmunology|April 20, 2010
B cell expression of the inhibitory Fc gamma receptor is unchanged in early MSManuel Comabella, Xavier Montalban, Kristina Kakalacheva, et al.
Journal of Virology|September 7, 2012
Persistence of Epstein-Barr virus in self-reactive memory B cellsSean I Tracy, Kristina Kakalacheva, Jan D Lünemann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosisIlijas Jelcić, Katharine C Hsu, Kristina Kakalacheva, et al.
Viruses|February 25, 2016
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte GlycoproteinKristina Kakalacheva, Stephan Regenass, Silke Wiesmayr, et al.
BMC Infectious Diseases|December 4, 2014
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85ARachel Tanner, Kristina Kakalacheva, Ellen Miller, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Future Microbiology|December 8, 2010
Epstein-Barr virus and multiple sclerosis: causation or association?Kristina Kakalacheva, Manuel Comabella
FEBS Letters|April 14, 2011
Environmental triggers of multiple sclerosisKristina Kakalacheva, Jan D Lünemann
Biochimica Et Biophysica Acta|July 6, 2010
Viral triggers of multiple sclerosisKristina Kakalacheva, Christian Münz, Jan D Lünemann
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2011
EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapyManuel Comabella, Kristina Kakalacheva, Jordi Río, et al.
Annals of Neurology|September 10, 2011
Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravisKristina Kakalacheva, Michael A Maurer, Björn Tackenberg, et al.
Journal of Neuroimmunology|April 20, 2010
B cell expression of the inhibitory Fc gamma receptor is unchanged in early MSManuel Comabella, Xavier Montalban, Kristina Kakalacheva, et al.
Journal of Virology|September 7, 2012
Persistence of Epstein-Barr virus in self-reactive memory B cellsSean I Tracy, Kristina Kakalacheva, Jan D Lünemann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosisIlijas Jelcić, Katharine C Hsu, Kristina Kakalacheva, et al.
Viruses|February 25, 2016
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte GlycoproteinKristina Kakalacheva, Stephan Regenass, Silke Wiesmayr, et al.
BMC Infectious Diseases|December 4, 2014
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85ARachel Tanner, Kristina Kakalacheva, Ellen Miller, et al.
Pageof 1